Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.
Boursier J, Canivet CM, Costentin C, Lannes A, Delamarre A, Sturm N, Le Bail B, Michalak S, Oberti F, Hilleret MN, Irles-Depé M, Fouchard I, Hermabessiere P, Barthelon J, Calès P, Cariou B, de Ledinghen V, Roux M. Boursier J, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2023 May;21(5):1243-1251.e12. doi: 10.1016/j.cgh.2022.02.059. Epub 2022 Mar 11. Clin Gastroenterol Hepatol. 2023. PMID: 35288342
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group. Ratziu V, et al. Among authors: de ledinghen v. BMC Gastroenterol. 2006 Feb 14;6:6. doi: 10.1186/1471-230X-6-6. BMC Gastroenterol. 2006. PMID: 16503961 Free PMC article.
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France. de Lédinghen V, et al. J Hepatol. 2006 Oct;45(4):592-9. doi: 10.1016/j.jhep.2006.05.008. Epub 2006 Jun 16. J Hepatol. 2006. PMID: 16837098 Clinical Trial.
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group. Poynard T, et al. Among authors: de ledinghen v. BMC Gastroenterol. 2006 Nov 10;6:34. doi: 10.1186/1471-230X-6-34. BMC Gastroenterol. 2006. PMID: 17096854 Free PMC article.
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D; Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA). Castéra L, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1489-98. doi: 10.1111/j.1365-2036.2007.03533.x. Epub 2007 Sep 28. Aliment Pharmacol Ther. 2007. PMID: 17903235 Free article.
423 results